Fragmentomics of cell-free DNA from targeted panels in genitourinary malignancies.
Amy K. Taylor(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), Hamid Emamekhoo(University of Wisconsin Carbone Cancer Center), Kyle T. Helzer(University of Wisconsin–Madison), Andrew J. Armstrong(Duke University), Kari B. Wisinski(University of Wisconsin Carbone Cancer Center), Yue Shi(University of Wisconsin–Madison), Matti Annala(Tampere University), Marina N. Sharifi(University of Wisconsin–Madison), Nan Sethakorn(University of Chicago), Alexander W. Wyatt(University of British Columbia), Jamie M. Sperger(University of Wisconsin–Madison), Rana R. McKay(University of California San Diego), Christos E. Kyriakopoulos(Dana-Farber Cancer Institute), David Kosoff(University of Wisconsin–Madison), Jennifer L. Schehr(University of Wisconsin–Madison), Katherine R. Kaufmann(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Shannon R. Reese(University of Wisconsin–Madison), Felix Y. Feng(University of Michigan)
Cited by 1
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k